Applied Therapeutics Inc (APLT)
8.69
-0.32
(-3.55%)
USD |
NASDAQ |
Nov 15, 16:00
8.79
+0.10
(+1.15%)
After-Hours: 20:00
Applied Therapeutics Total Liabilities (Quarterly): 100.67M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 100.67M |
| June 30, 2024 | 55.39M |
| March 31, 2024 | 83.94M |
| December 31, 2023 | 71.98M |
| September 30, 2023 | 56.24M |
| June 30, 2023 | 47.98M |
| March 31, 2023 | 34.08M |
| December 31, 2022 | 34.30M |
| September 30, 2022 | 47.05M |
| June 30, 2022 | 52.37M |
| March 31, 2022 | 22.99M |
| December 31, 2021 | 27.35M |
| Date | Value |
|---|---|
| September 30, 2021 | 31.85M |
| June 30, 2021 | 24.52M |
| March 31, 2021 | 21.00M |
| December 31, 2020 | 22.57M |
| September 30, 2020 | 21.90M |
| June 30, 2020 | 20.37M |
| March 31, 2020 | 10.05M |
| December 31, 2019 | 15.78M |
| September 30, 2019 | 6.517M |
| June 30, 2019 | 6.78M |
| March 31, 2019 | 44.79M |
| December 31, 2018 | 39.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.05M
Minimum
Mar 2020
100.67M
Maximum
Sep 2024
40.12M
Average
32.96M
Median
Total Liabilities (Quarterly) Benchmarks
| ResMed Inc | 2.027B |
| Axonics Inc | 109.68M |
| Organon & Co | 12.26B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.57M |
| Shareholders Equity (Quarterly) | 5.892M |
| Current Ratio | 1.057 |
| Net Debt Paydown Yield | 0.03% |